[1]
ReisJ.R.C. dos, FurtadoP.P.O., ResendeL. dos S. and ReisB.C.C. 2022. Prescription of Glucagon-Like Peptide 1 (GLP-1) in the treatment of patients with type 2 diabetes and obesity: a literature review. Revista Eletrônica Acervo Médico. 11, (Jun. 2022), e10289. DOI:https://doi.org/10.25248/reamed.e10289.2022.